Distigmine
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151523This classification denotes a cholinesterase inhibitor with the molecular formula C22H32N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T940307O7B, chemically known as 3,3-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis(1-methylpyridinium) dibromide but generally known as distigmine, which bears US NIH Compound Identifier 27522. European Medicines Agency schedules Distigmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01797MIG. World Health Organization schedules distigmine in its Anatomical Therapeutic Chemical (ATC) Classification. DISTIGMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, DISTIGMINE remains the US FDA Preferred Term for this commodity. SMILES: BR.BR.O(C(=O)N(CCCCCCN(C)C(=O)OC1C[N](CCC1)C)C)C1C[N](CCC1)C. .
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.